Article
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.
Nature medicine - 1 Jun 2011
Delahaye Nicolas F, Rusakiewicz Sylvie, Martins Isabelle, Ménard Cédric, Roux Stephan, Lyonnet Luc, Paul Pascale, Sarabi Matthieu, Chaput Nathalie, Semeraro Michaela, Minard-Colin Véronique, Poirier-Colame Vichnou, Chaba Kariman, Flament Caroline, Baud Véronique, Authier Hélène, Kerdine-Römer Saadia, Pallardy Marc, Cremer Isabelle, Peaudecerf Laetitia, Rocha Bénédita, Valteau-Couanet Dominique, Gutierrez Javier Celis, Nunès Jacques A, Commo Frédéric, Bonvalot Sylvie, Ibrahim Nicolas, Terrier Philippe, Opolon Paule, Bottino Cristina, Moretta Alessandro, Tavernier Jan, Rihet Pascal, Coindre Jean-Michel, Blay Jean-Yves, Isambert Nicolas, Emile Jean-François, Vivier Eric, Lecesne Axel, Kroemer Guido, Zitvogel Laurence
Abstract excerpt
The natural killer (NK) cell receptor NKp30 is involved in the recognition of tumor and dendritic cells (DCs). Here we describe the influence of three NKp30 splice variants on the prognosis of gastrointestinal sarcoma (GIST), a malignancy that expresses NKp30 ligands and that is treated with NK-s...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
